CINECA IRIS Institutional Research Information System

LEUCI, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.606
AS - Asia 1.399
EU - Europa 1.212
SA - Sud America 155
Continente sconosciuto - Info sul continente non disponibili 123
AF - Africa 27
OC - Oceania 15
Totale 5.537
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.502
IT - Italia 571
SG - Singapore 523
CN - Cina 384
VN - Vietnam 165
BR - Brasile 108
FI - Finlandia 102
DE - Germania 94
IE - Irlanda 83
SE - Svezia 76
FR - Francia 68
CA - Canada 55
HK - Hong Kong 54
BD - Bangladesh 52
KR - Corea 49
IN - India 46
GB - Regno Unito 44
NL - Olanda 37
PL - Polonia 33
JP - Giappone 25
UA - Ucraina 25
ID - Indonesia 21
MX - Messico 20
ES - Italia 18
TW - Taiwan 17
IQ - Iraq 15
AR - Argentina 13
AU - Australia 13
TR - Turchia 13
JM - Giamaica 12
AT - Austria 11
CL - Cile 11
CH - Svizzera 9
ZA - Sudafrica 9
EC - Ecuador 8
TH - Thailandia 8
BE - Belgio 7
VE - Venezuela 7
RU - Federazione Russa 6
DZ - Algeria 5
NO - Norvegia 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
CR - Costa Rica 3
DK - Danimarca 3
HN - Honduras 3
HU - Ungheria 3
NI - Nicaragua 3
TN - Tunisia 3
UY - Uruguay 3
EG - Egitto 2
GA - Gabon 2
GT - Guatemala 2
IR - Iran 2
JO - Giordania 2
LT - Lituania 2
MA - Marocco 2
MQ - Martinica 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PR - Porto Rico 2
RO - Romania 2
UZ - Uzbekistan 2
AO - Angola 1
BH - Bahrain 1
BY - Bielorussia 1
DJ - Gibuti 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 5.415
Salva come PNG Salva come JPEG
Città #
Singapore 337
Ashburn 321
San Jose 211
Chandler 171
Beijing 144
Turin 124
Santa Clara 113
Fairfield 99
Houston 95
Dublin 83
Torino 61
Helsinki 58
Seattle 52
Woodbridge 50
The Dalles 46
Milan 42
Ho Chi Minh City 41
Los Angeles 41
Dallas 40
Jacksonville 40
Hong Kong 39
New York 37
Seoul 34
Wilmington 34
Nyköping 33
Hanoi 32
Munich 32
Hefei 30
Council Bluffs 29
Ann Arbor 28
Dong Ket 27
Lauterbourg 27
Columbus 26
Cambridge 25
Shanghai 25
Warsaw 24
Boardman 23
Guangzhou 22
Pisa 22
Rome 22
Medford 21
Buffalo 20
Fremont 19
Princeton 19
Tokyo 19
Villeurbanne 18
Washington 18
Dearborn 17
Jakarta 16
Montreal 16
Phoenix 16
Turku 16
Chicago 15
Bengaluru 13
Boston 13
San Diego 12
São Paulo 12
Brooklyn 11
Nanjing 11
Naples 11
Taipei 11
Toronto 11
Kingston 9
Mexico City 9
Nuremberg 9
Pieve Emanuele 9
Santiago 9
Denver 8
Florence 8
Lappeenranta 8
Silver Spring 8
Stockholm 8
Wuhan 8
Amsterdam 7
Atlanta 7
Detroit 7
Haiphong 7
Hangzhou 7
Johannesburg 7
Kunming 7
Orem 7
Pune 7
San Francisco 7
Frankfurt am Main 6
Genoa 6
Mumbai 6
Redondo Beach 6
The Bronx 6
Wroclaw 6
A Coruña 5
Birmingham 5
London 5
Manchester 5
Philadelphia 5
Sydney 5
Xian 5
Baghdad 4
Barcelona 4
Belo Horizonte 4
Bern 4
Totale 3.325
Salva come PNG Salva come JPEG
Nome #
Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells 505
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody 372
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. 262
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy 244
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells 237
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 236
CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy 230
Novel lymphocyte-independent antitumor activity by PD-1 blocking antibody against PD-1+ chemoresistant lung cancer cells 226
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 217
Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells. 210
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy 201
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective 183
Abstract 3998: Preclinical efficacy of a synthetic Notch-based combinatorial immunotherapy against colorectal cancer with HER2 amplification 175
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers. 173
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma 171
Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features. 170
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST 158
Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich Syndrome gene 156
Adoptive immunotherapy against sarcomas. 153
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification 152
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma 148
Gene-modified T lymphocytes in the setting of hematopoietic cell transplantation: potential benefits and possible risks. 148
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis 141
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study 140
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers 133
Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectors. 121
The cGAS-STING pathway is a master regulator of OCT4 expression in persistent sarcoma cells and enhances cellular immunotherapy with NK and CIK lymphocytes 103
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade 98
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation 74
Totale 5.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.752
article - articoli 0
book - libri 0
conference - conferenze 1.168
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022260 0 0 0 11 10 15 25 18 8 32 90 51
2022/2023535 35 42 6 63 41 122 34 46 76 17 37 16
2023/2024312 32 48 25 15 20 58 21 15 1 12 31 34
2024/2025850 17 44 57 63 155 68 25 72 66 91 92 100
2025/20262.003 211 82 94 260 256 89 276 78 168 128 117 244
2026/2027445 100 110 181 54 0 0 0 0 0 0 0 0
Totale 5.537